ACTRN12616001043426已完成未知
High-risk patients with operable breast cancer treated with adjuvant dose-dense sequential chemotherapy. A translational study of investigating biomarkers with prognostic value on disease-free survival and overall survival (HE10/10)
Hellenic Cooperative Oncology Group0 个研究点目标入组 1,060 人开始时间: 2016年8月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,060
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- Female
入选标准
- •Pre and post menopausal patients with intermediate or high-risk operable breast cancer as defined by the Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005. A.Goldhirsch, J. H. Glick, R. D. Gelber, A. S. Coates, B. Thurlimann, H.J. Senn & Panel Members, Annals of Oncology 16: 1569–1583, 2005 who received dose-dense sequential adjuvant chemotherapy.
排除标准
- •Documented residual or metastatic disease
研究者
相似试验
已完成
不适用
Epirubicin/Paclitaxel/Cyclophosphamide-Methotrexate-Fluorouracil (E-T-CMF) as adjuvant chemotherapy in high-risk patients with operable breast cancerCancer - BreastBreast CancerACTRN12615000161527Hellenic Cooperative Oncology Group1,000
已完成
3 期
Epirubicin-Paclitaxel-Cyclophosphamide Methotrexate Fluorouracil (E-T-CMF) versus Epirubicin-Cyclophosphamide Methotrexate Fluorouracil (E-CMF) as adjuvant chemotherapy in high risk patients with operable breast cancer. A phase III study conducted by the Hellenic Cooperative Oncology Group (HE10/97)ACTRN12611000506998Hellenic Cooperative Oncology Group600
已完成
不适用
Selection of Breast Cancer Patients with Low-risk Tumors using MR Imagingbreast cancerNL-OMON36966niversitair Medisch Centrum Utrecht60
已完成
不适用
Prevention of breast cancer in high risk women by monitoring microrna expression in nipple aspirate fluid.breast carcinoma100836241000629110006232breast cancerNL-OMON44762niversitair Medisch Centrum Utrecht720
已完成
不适用
High Dose Therapy in Poor-Risk Primary Breast CancerBreastCancerBreast cancerISRCTN52623943Amgen Limited (UK)